Racial Disparities in Melanoma Care: Steps to Improve Care

Faculty

Monica E. Peek, MD, MPH, MSc
(she/her/hers)
Ellen H. Block Professor of Health Justice in the Department of Medicine
Associate Director, Chicago Center for Diabetes Translation Research
Director of Research, MacLean Center for Clinical Medical Ethics
The University of Chicago
Chicago, IL
Monica E. Peek, MD, MPH, MSc

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.

Andrew F. Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion, New York, NY
Department of Dermatology, Weill Cornell Medicine
Professor of Clinical Dermatology, Weill Cornell Medical College
Andrew F. Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion, New York, NY

Andrew F. Alexis, MD, MPH is the Vice-Chair for Diversity and Inclusion for the Department of Dermatology and Professor of Clinical Dermatology at Weill Cornell Medical College in New York City. He is the former Chair of the Department of Dermatology at Mount Sinai Morningside and Mount Sinai West. Having served as Director of the first-of-its-kind Skin of Color Center for over 15 years, his work has helped to advance patient care, research, and education pertaining to dermatologic disorders that are prevalent in populations with skin of color.

Dr. Alexis received his medical degree from Columbia University Vagelos College of Physicians & Surgeons and his Master of Public Health at Columbia University Mailman School of Public Health. He completed his dermatology residency at Weill Cornell Medicine, followed by a fellowship in dermatopharmacology at NYU Langone’s Ronald O. Perelman Department of Dermatology.

Dr. Alexis has published more than 90 articles in peer-reviewed journals including the British Journal of Dermatology, Journal of the American Academy of Dermatology, and JAMA Dermatology among others. He has co-edited two textbooks and authored over 10 book chapters. Dr. Alexis is a frequent lecturer at national and international conferences and has been invited as a Visiting Professor or Grand Rounds speaker at many prestigious academic institutions.

Dr. Alexis has held numerous leadership positions in professional organizations including Past President of the New York Dermatological Society, Past President of the New York Academy of Medicine Dermatology Section, Secretary/Treasurer of the Skin of Color Society and Chair of the Diversity Task Force Committee for the American Academy of Dermatology. He currently serves as Co-Chair of the Scientific Committee of the Skin of Color Society, and is a member of the Board of Directors of the American Dermatological Association and the Cicatricial Alopecia Research Foundation.

Dr. Alexis has appeared on ABC, CBS, NBC, and FOX television news programs and has been quoted in numerous leading publications, including the New York Times, Wall Street Journal, Forbes, Vogue, Allure, and Essence. He is listed in Castle Connolly’s Top Doctors ™ and Super Doctors®

Statement of Need

While melanoma incidence is lower in individuals with darker skin tones, persistent disparities exist in mortality rates, particularly among African American/Black and Hispanic patients. The many factors for higher mortality rates in racial and ethnic minority populations include low public awareness of at-risk populations and a lower index of concern by dermatologists and other clinicians. Additionally, melanoma types that are more common in skin of color are deemed “rare” and typically occur in areas of the body not exposed to UV radiation. Hence, melanoma lesions are more likely to appear in places less frequently surveyed, leading to later diagnoses and worse prognosis. This has led to an education gap in clinicians, particularly in diagnosing and screening practices.

This live CMEO Briefcase will focus on three patients from racial and ethnic minority populations with melanoma and outline best practices for screening to reduce disparities and improve melanoma morbidity and mortality rates in patients of color.

Learning Objectives

At the end of this CME/CE activity, participants should be able to implement best practices to improve melanoma morbidity and mortality rates in patients of color.

Financial Support

Supported by an educational grant from the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies.

Target Audience

Physicians, nurse practitioners (NPs), physician associates (PAs), nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hour. Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from Jointly Accredited Organizations. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.75

This application-based activity is approved for 0.75 contact hour (0.075 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-199-H01-P

Physician Assistants (AAPA): 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC 0.75

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.


Dr. Peek has no disclosures to report.


Dr. Alexis reports that he receives grants from Almirall; Amgen Inc; Arcutis Biotherapeutics; Bristol Myers Squibb; Cara Therapeutics; Dermavant Sciences, Inc.; Galderma; Leo Pharma; Menlo Therapeutics Inc.; Novartis; and Valeant (Bausch Health). He is a consultant for Abbvie Inc.; AllerGen; Almirall; Amgen Inc.; Arcutis Biotherapeutics; Bausch Health; Beiersdorf; Bristol Myers Squibb; Dermavant Sciences, Inc.; Galderma; Janssen; Leo Pharma; L’Oreal; Pfizer Inc.; Sanofi-Regeneron; Sol-Gel Technologies Ltd; UCB; Valeant (Bausch Health); VisualDx; and Vyne Therapeutics. He is on the speakers bureau for Pfizer, Inc; Regeneron; and SANOFI-Genzyme.

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer) has no disclosures to report.
  • Noreen Iftikhar, MD (planning committee) has no disclosures to report.
  • Kathleen A. Blake, PhD (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.
  • Disclosures were obtained from the CME Outfitters, LLC, staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 


NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-22-199-H01-P.

 

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

 

BC-042-011322-57

Racial Disparities in Melanoma Care: Steps to Improve Care
Event Date: 01/13/2022 at 5:00 am EST